Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patients

OBJECTIVES: This 109-week, nonrandomized, observational study of mucopolysaccharidosis II (MPS II) patients already enrolled in the Hunter Outcome Survey (HOS) (NCT00882921), assessed the long-term immunogenicity of idursulfase, and examined the effect of idursulfase-specific antibody generation on...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliani, R., Harmatz, P., Jones, S.A., Mendelsohn, N.J., Vellodi, A., Qiu, Y., Hendriksz, C.J., Vijayaraghavan, S., Whiteman, D.A.H., Pano, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320046/
https://www.ncbi.nlm.nih.gov/pubmed/28243577
http://dx.doi.org/10.1016/j.ymgmr.2017.01.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320046/
https://www.ncbi.nlm.nih.gov/pubmed/28243577
http://dx.doi.org/10.1016/j.ymgmr.2017.01.014

Ejemplares similares